SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Amarin Corp. PLC ADS (AMRN)

AMRN RSS Feed
Add AMRN Price Alert      Hide Sticky   Hide Intro
Moderator: Dancing in the dark, zumantu, Biobillionair, HDGabor, marzan, lbwagain
Search This Board: 
Last Post: 8/17/2017 9:41:32 AM - Followers: 438 - Board type: Free - Posts Today: 20

AMARIN
Home page
VASCEPA
Savings Card Program
FDA Orange Book: VASCEPA
Amarin's Patents (Author: @lowlevelowl on StockTwits)
Trials
Marine Trial hits all EndPoints: http://investor.amarincorp.com/releasedetail.cfm?ReleaseID=533361
Transcript MARINE trial CC: http://files.shareholder.com/downloads/AMRN/1080589559x0x430674/E6D77DA6-F44C-405F-B479-9A5C31E7A6E3/AmarinCorporation112910_Transcript.pdf
Marine Trial Presentation: http://files.shareholder.com/downloads/AMRN/1080589559x0x423194/424D45B3-62CC-4A84-81D7-F5264EF82A11/MARINE_RESULTS_Nov_29_2010.pdf
Anchor Trial completes Enrollment: http://files.shareholder.com/downloads/AMRN/1080589559x0x428546/275b9676-c0cf-4bd0-a69b-e80e26433822/AMRN_News_2010_12_16_General_Releases.pdf
Anchor Trial hits all EndPoints: http://investor.amarincorp.com/releasedetail.cfm?ReleaseID=569648
Anchor Trial Conf Call (Apr '11):  http://www.investorcalendar.com/IC/CEPage.asp?ID=164219
Additional Marine Trial Results:  http://investor.amarincorp.com/releasedetail.cfm?ReleaseID=579260


The EPA Drug Initiative (EPADI)


AMRN SITES / QUOTES:

NASDAQ: AMRN 
Yahoo: AMRN 
Seeking Alpha: AMRN
finviz: AMRN
StreetInsider: AMRN


OTHER INFORMATION

American Heart Assocuation: 
Good vs Bad Cholesterol

Lovaza Label, etc

Excellent Blog Article featuring Lovaza data comparison - http://www.chasingthealpha.com/2010/11/amrn-look-at-tg-and-ldl-levels.html
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/21-654_Omacor.cfm
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021853_021654s016_omacor_toc.cfm

Various Trials, Statins/Lovaza etc:

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2813819/pdf/mayoclinproc_85_2_004.pdf
http://www.ncbi.nlm.nih.gov/pubmed/20877395
http://www.ncbi.nlm.nih.gov/pubmed/19002433
http://www.ncbi.nlm.nih.gov/pubmed/15250255

TriCor label, FIELD trial - http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021656s019lbl.pdf  
ACCORD trial -
http://www.endocrinetoday.com/view.aspx?rid=61934 
Jelis Trial (Japan) -
http://www.ccmdweb.org/dsl/middle.aspx?Slideid=2643&Catid=1043

transcript, ENDOCRINOLOGIC AND METABOLIC DRUGS ADVISORY COMMITTEE, 10/16/2013: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM376102.pdf

AMRN
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
AMRN News: Amarin's REDUCE-IT Cardiovascular Outcomes Study of Vascepa to Continue as Planned at Recommendation of Independent Data Moni... 08/14/2017 06:00:00 AM
AMRN News: Securities Registration: Employee Benefit Plan (s-8) 08/02/2017 05:06:42 PM
AMRN News: Quarterly Report (10-q) 08/02/2017 06:38:43 AM
AMRN News: Current Report Filing (8-k) 08/02/2017 06:31:46 AM
AMRN News: Amarin Reports Second Quarter 2017 Financial Results and Provides Update on Operations 08/02/2017 05:30:00 AM
PostSubject
#112430   "the rates for placebo and for vascepa will rafunrafun 08/17/17 09:47:49 AM
#112429   tasty... Yes the discussion (education) had merit ...My ideas jessellivermore 08/17/17 09:46:12 AM
#112428   Lads -- the rates for placebo and for tasgrewaf 08/17/17 09:41:32 AM
#112427   Was there merit in my ideas? I would tasgrewaf 08/17/17 09:29:25 AM
#112426   Or maybe they do and we don't ?? Yoyippie 08/17/17 09:27:53 AM
#112425   BB, Raf has a tendency to go against marzan 08/17/17 08:42:05 AM
#112424   "All ideas have merit" jessellivermore 08/17/17 08:28:22 AM
#112423   Many posts discuss the anemic pps as it shadolane 08/17/17 08:14:13 AM
#112422   Your correct - I think in the long BioChica 08/17/17 07:56:42 AM
#112421   Again, 4.9 is out of thin air. If rafunrafun 08/17/17 07:35:00 AM
#112420   Raf- It can't be just about anything, these Biobillionair 08/17/17 07:20:09 AM
#112419   Have fun lucky guy! I miss sailing... BioChica 08/17/17 07:14:53 AM
#112418   I think that its in the high 5s rafunrafun 08/17/17 07:11:37 AM
#112417   Well even if you had the exact total BioChica 08/17/17 07:10:10 AM
#112416   The fact 100% is pushed to 2018 and Biobillionair 08/17/17 07:06:45 AM
#112415   Raf..lets use 5.0% out of "thin air". Biobillionair 08/17/17 07:03:58 AM
#112414   But you pulled up 5.5 out of thin rafunrafun 08/17/17 06:48:28 AM
#112413   Decreased circulating dihomo-gamma-linolenic acid levels are associated with zumantu 08/17/17 06:29:41 AM
#112412   Adjust the placebo rate down to 5.5 and Biobillionair 08/17/17 06:12:17 AM
#112411   A wise man would calculate December tax loss Danburydude 08/17/17 01:17:32 AM
#112409   No, the market does not know what the rafunrafun 08/16/17 09:37:36 PM
#112407   And placebo Biobillionair 08/16/17 09:23:21 PM
#112404   An easy reasonableness check of the rate is tasgrewaf 08/16/17 07:05:02 PM
#112403   m- is there a 90% chance ... that HDGabor 08/16/17 06:12:31 PM
#112402   understood and thanks for the clarification. Is there mrmainstreet 08/16/17 05:51:38 PM
#112401   m- It is calculated by using PY and number HDGabor 08/16/17 05:48:42 PM
#112400   HDG quick question, and sorry of this has mrmainstreet 08/16/17 05:28:13 PM
#112398   Expect full 10 months review with Ad Com, Biobillionair 08/16/17 03:11:23 PM
#112397   Sts- I somewhat disagree about options being dead. Benny7459 08/16/17 02:46:53 PM
#112395   Update to that article - DVAX's hepatitis B sts66 08/16/17 02:25:24 PM
#112394   Given what we know about the safety sts66 08/16/17 02:15:43 PM
#112393   AV1177 Could you post your views following no AVII77 08/16/17 02:11:53 PM
#112392   t- Don't mix the design with the expectation ... HDGabor 08/16/17 01:49:11 PM
#112391   Be patient. everyonesguess 08/16/17 01:48:42 PM
#112390   Lovaza sold $1B+/yr before the FDA declared TGs sts66 08/16/17 01:31:59 PM
#112389   Thanks for reminding us about the CANTOS results sts66 08/16/17 01:20:54 PM
#112388   sts- (and to all) HDGabor 08/16/17 01:04:42 PM
#112387   The stuff either works or it doesn't. We sts66 08/16/17 01:04:28 PM
#112386   Here's what they said in their May 2016 tasgrewaf 08/16/17 12:54:13 PM
#112385   - additional app. 300 events (app. +21-22%) could sts66 08/16/17 12:18:30 PM
#112384   AMRN options are, or should be, officially dead sts66 08/16/17 12:14:24 PM
#112383   AV1177 Could you post your views Whalatane 08/16/17 11:51:54 AM
#112382   there were two primary criteria the DMC had sts66 08/16/17 11:51:13 AM
#112381   Benny thanks for posting that comment from IR. mrmainstreet 08/16/17 11:48:05 AM
#112380   t- It was originally designed to be 90% HDGabor 08/16/17 11:40:57 AM
#112379   Cmon now I know you're dying to move tasgrewaf 08/16/17 11:29:27 AM
#112378   @CBB, thank you for the response Dancing in the dark 08/16/17 11:25:35 AM
#112377   tasty... Cmon now I know you're dying to move jessellivermore 08/16/17 11:14:10 AM
#112376   Chris -- that was the final design. tasgrewaf 08/16/17 11:06:29 AM
#112375   Correct JL! And when one adds other safety zz1 08/16/17 10:58:21 AM
PostSubject